In the UK coronavirus infections are still climbing rapidly and a slowly increasing lockdown is changing daily life out of all recognition.
But in China, where the outbreak began, the storm seems to have passed.
In early February, two completely new hospitals were rush-built in the city of Wuhan, Hubei province.
This week, after the number of new infections in Hubei province is down to single figures, the hospitals have been closed.
The hospitals – with a capacity of 2,000 beds – are no longer needed.
A video shot by the Chinese government showed smiling workers taking off their medical masks as a sign that the worst of the crisis was over.
This comes as hope is growing of a vaccine coming to the UK.
Playboy model says she hopes coronavirus wipes out half of mankind to save Earth
One patient in Wuhan, Zhang Guangfen, has made a complete recovery from the coronavirus following six days of intensive treatment in Wuhan. She is 103-years-old.
Ms Zhang was cured within less than a week because "she did not have many underlying health conditions", her doctor Zeng Yulan told reporters.
And it’s not just Chinese doctors that are having success with coronavirus treatment.
Coronavirus crisis sees Amsterdam's weed cafés overrun with panic buyers before lockdown
Doctors in India have successfully treated coronavirus patients with a cocktail of drugs developed to treat of HIV, swine flu, and malaria.
Doctors at Sawai Man Singh (SMS) Hospital, Jaipur, treated an Italian tourist with a daily combination of two drugs useful in HIV treatment– Lopinavir and Ritonavir.
The doctors also gave the woman a malaria medication, chloroquine, and oseltamivir which was developed during the swine flu epidemic.
Over in the US, Johns Hopkins immunologist Arturo Casadevall has developed a treatment using blood plasma from people who have recovered from the disease.
"Deployment of this option requires no research or development," he said.
Coronavirus lockdown hitting supplies of Chinese sex dolls as factories close
"It could be deployed within a couple of weeks since it relies on standard blood-banking practices."
Looking further ahead a German biotech company, BioNTech, expects to begin trials of a Covid-19 vaccine by April.
Source: Read Full Article